HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Inflammatory Bowel Disease 16

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Disease Context: Research Results

Digestive System Diseases: 1042
- Gastrointestinal Diseases: 5874
  - Gastroenteritis: 4572
    - Inflammatory Bowel Diseases: 24316
      - Inflammatory Bowel Disease 16: 2
  - Intestinal Diseases: 1601
    - Inflammatory Bowel Diseases: 24316
      - Inflammatory Bowel Disease 16: 2

Related Diseases

1.	Crohn Disease (Crohn's Disease)
2.	Ulcerative Colitis
3.	Polymyositis
4.	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
5.	Giant Cell Arteritis (Horton Disease)

Experts

1.	Agmon-Levin, Nancy: 1 article (05/2012)
2.	Altman, Arie: 1 article (05/2012)
3.	Amital, Howard: 1 article (05/2012)
4.	Anaja, Juan-Manuel: 1 article (05/2012)
5.	Barzilai, Ori: 1 article (05/2012)
6.	Bizzaro, Nicola: 1 article (05/2012)
7.	Bombardieri, Stefano: 1 article (05/2012)
8.	Damoiseaux, Jan: 1 article (05/2012)
9.	Gilburd, Boris: 1 article (05/2012)
10.	Ram, Maya: 1 article (05/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Inflammatory Bowel Disease 16:

1.	Azathioprine (Imuran)FDA LinkGeneric 07/01/2003 - "We investigated the efficacy of azathioprine in controlling the disease relapse (in combination with other drugs) in 29 patients with inflammatory bowel disease (16 with ulcerative colitis and 13 with Crohn's disease). "
2.	Immunoglobulin M (IgM)IBA 05/01/2012 - "The prevalence of IgM anti-rubella antibodies was significantly higher in 5/14 AID, namely in patients with giant cell arteritis (33.3%), primary biliary cirrhosis (24%), antiphospholipid syndrome (20.6%), polymyositis (16%), and inflammatory bowel disease (16%). "
3.	rubella antibodiesIBA 05/01/2012 - "The prevalence of IgM anti-rubella antibodies was significantly higher in 5/14 AID, namely in patients with giant cell arteritis (33.3%), primary biliary cirrhosis (24%), antiphospholipid syndrome (20.6%), polymyositis (16%), and inflammatory bowel disease (16%). "